Panamá

República de Panamá

Calle 50, Edificio Embajador,
Mezzanine 1, Bella Vista
Ciudad de Panamá, República de Panamá
T: +(507) 209 6614
info@ecija.com

Partners

Our Team

Nombre Área de práctica
Córdoba Armando Corporate / M&A, Tax, Intellectual & Industrial property, Information Technology
De La Cruz Barraza Lida Aida Administrative
Guerra Arango Ana Raquel Paralegal
Guerra Saavedra Diego Alejandro Legal
Milhem Harari Nicole Immigration
Rivera Tovar Angélica Corporate / M&A
Saavedra Pérez Wendy Dispute Resolution: Litigation and arbitration
Shamah Daniel Corporate / M&A, Banking Law
Vargas Antonio Laboral Law, Dispute Resolution: Litigation and arbitration, Distribution and consumer law
 

Latest news

Global Law Telework 20202 Wednesday, 16 September, 2020

Global Telework Law Report 2020

Publications

It is not surprising that the celebration of the “International Telework Day”, 16 September, coincides with the “World Day for the Preservation of the Ozone Layer”, since this type of work is related to the essential contribution it makes to the care and protection of the environment because, for example, as there is less travel […]

Día Mundial del Medio Ambiente Tuesday, 9 June, 2020

International challenges for environment- World Environment Day

Publications

World Environment Day was established by the United Nations (UN) in its resolution (A/RES/2994 (XXVII)1 of 15 December 1977. It has been celebrated since 1974 on 5 June each year, the date on which the Stockholm Conference began in 1972, whose central theme was the Environment, and two days after Environment Day the UN General […]

COVID-19 Vaccines patent Tuesday, 12 May, 2020

Will COVID-19 Vaccines Be Subject to Compulsory Patent Licenses?

ECIJA in the media

This article was originally published by Law.Com. Granting patents in favor of a specific company or organization could undermine the development and wide-scale distribution of virus treatments, lawyers say. As the COVID-19 virus permeates more corners of the world, lawyers anticipate an increase in litigation related to the scope of patents for treatments and vaccines. […]

Enter your email and receive our newsletter with the latest news